Uncover the groundbreaking insights and cutting-edge research presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2026), a pivotal gathering of scientific minds. Since its inception in 1993, CROI has been a beacon for basic scientists and clinical investigators, offering a platform to explore, debate, and critique the intricate world of human retroviruses and their impact on health. The unique synergy between basic science and clinical investigation has been the driving force behind the conference's success, fostering a collaborative environment that accelerates progress in HIV and AIDS research. But here's where it gets controversial: while CROI primarily focuses on HIV, hepatitis viruses, SARS-CoV-2 (including long COVID), and mpox, the conference also highlights the lesser-known retroviruses and their associated conditions, challenging the notion that some infections are more 'deserving' of attention than others. This is the part most people miss: the conference isn't just about the big names; it's about the entire spectrum of retroviruses and their impact on global health. By embracing this holistic approach, CROI encourages a deeper understanding of the interconnectedness of these diseases and the need for comprehensive research strategies. So, are you ready to dive into the world of retroviruses and discover the groundbreaking research presented at CROI 2026? Your insights and comments are invaluable, and we invite you to join the conversation and share your thoughts in the comments section below.
